lamivudine has been researched along with Carcinoma, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, JS; Choi, MS; Gwak, GY; Im, YH; Kang, ES; Kim, KH; Lee, JE; Nam, SJ; Park, YH; Yang, JH; Yun, J | 1 |
1 other study(ies) available for lamivudine and Carcinoma, Anaplastic
Article | Year |
---|---|
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.
Topics: Adult; Aged; Algorithms; Anthracyclines; Antibiotic Prophylaxis; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Carcinoma; Case-Control Studies; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Hepatitis B; Humans; Incidence; Lamivudine; Middle Aged; Postoperative Complications; Retrospective Studies | 2011 |